Opin vísindi

Novel oxygen desaturation parameters are associated with cardiac troponin I : Data from the Akershus Sleep Apnea Project

Novel oxygen desaturation parameters are associated with cardiac troponin I : Data from the Akershus Sleep Apnea Project


Titill: Novel oxygen desaturation parameters are associated with cardiac troponin I : Data from the Akershus Sleep Apnea Project
Höfundur: Sigurdardottir, Fjola D.
Øverby, Caroline Tonje
Nikkonen, Sami
Karhu, Tuomas
Dammen, Toril
Nordhus, Inger Hilde
Thorshov, Thea
Einvik, Gunnar
Kainulainen, Samu
Leppänen, Timo
... 4 fleiri höfundar Sýna alla höfunda
Útgáfa: 2022-03-15
Tungumál: Enska
Umfang: 710100
Háskóli/Stofnun: Landspitali - The National University Hospital of Iceland
Deild: Department of Engineering
Department of Computer Science
Birtist í: Journal of Sleep Research; ()
ISSN: 0962-1105
DOI: 10.1111/jsr.13581
Efnisorð: Náttúrufræðingar; Svefnrannsóknir; Akershus Sleep Apnea Project; obstructive sleep apnea; oxygen desaturation parameters; polysomnography; troponin I; Cognitive Neuroscience; Behavioral Neuroscience
URI: https://hdl.handle.net/20.500.11815/3182

Skoða fulla færslu

Tilvitnun:

Sigurdardottir , F D , Øverby , C T , Nikkonen , S , Karhu , T , Dammen , T , Nordhus , I H , Thorshov , T , Einvik , G , Kainulainen , S , Leppänen , T , Arnardóttir , E S , Töyräs , J , Omland , T & Hrubos-Strøm , H 2022 , ' Novel oxygen desaturation parameters are associated with cardiac troponin I : Data from the Akershus Sleep Apnea Project ' , Journal of Sleep Research . https://doi.org/10.1111/jsr.13581

Útdráttur:

Novel diagnostic markers for obstructive sleep apnea beyond the apnea–hypopnea index (AHI) have been introduced. There are no studies on their association with markers of subclinical myocardial injury. We assessed the association between novel desaturation parameters and elevated cardiac troponin I and T. Participants with polysomnography (498) from the Akershus Sleep Apnea study were divided into normal and elevated biomarker groups based on sex-specific concentration thresholds (cardiac troponin I: ≥4 ng/L for women, ≥6 ng/L for men; and cardiac troponin T: ≥7 ng/L for women, ≥8 ng/L for men). Severity of obstructive sleep apnea was evaluated with the AHI, oxygen desaturation index, total sleep time with oxygen saturation below 90% (T90), lowest oxygen saturation (Min SpO2%), and novel oxygen desaturation parameters: desaturation duration and desaturation severity. How the AHI and novel desaturation parameters predicted elevated cardiac troponin I and cardiac troponin T levels was assessed by the area under the curve (AUC). Based on multivariable-adjusted linear regression, the AHI (β = 0.004, p = 0.012), desaturation duration (β = 0.007, p = 0.004), and desaturation severity (β = 0.147, p = 0.002) were associated with cardiac troponin I levels but not cardiac troponin T. T90 was associated with cardiac troponin I (β = 0.006, p = 0.009) and cardiac troponin T (β = 0.005, p = 0.007). The AUC for the AHI 0.592 (standard error 0.043) was not significantly different from the AUC of T90 (SD 0.640, p = 0.08), desaturation duration 0.609 (SD 0.044, p = 0.42) or desaturation severity 0.616 (SD 0.043, p = 0.26) in predicting myocardial injury as assessed by cardiac troponin I. Oxygen desaturation parameters and the AHI were associated with cardiac troponin I levels but not cardiac troponin T levels. Novel oxygen desaturation parameters did not improve the prediction of subclinical myocardial injury compared to the AHI.

Athugasemdir:

Funding Information: Fjola D. Sigurdardottir was funded by a PhD fellowship from the South‐Eastern Norway Regional Health Authority. Caroline Tonje Øverby was funded by NordForsk (NordSleep project 90458) via the Norwegian Research Council (Norsk Forskningsråd 298845). Tuomas Karhu was funded by the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (5041787) and Tampere Tuberculosis Foundation. Timo Leppänen was funded by the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 965417), NordForsk (NordSleep project 90458) via Business Finland (5133/31/2018), the Academy of Finland (323536), the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (5041767 and 5041794), the Finnish Cultural Foundation ‐ North Savo Regional Fund, and Tampere Tuberculosis Foundation. Abbott Diagnostics has provided the reagents for cTnI analysis. Torbjørn Omland has received consultant and/or speaker honoraria from Abbott Diagnostics, Bayer, Roche Diagnostics, Novartis, and CardiNor and has received research support from AstraZeneca, Abbott Diagnostics, Roche Diagnostics and SomaLogic via Akershus University Hospital. Publisher Copyright: © 2022 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.

Skrár

Þetta verk birtist í eftirfarandi safni/söfnum: